» Articles » PMID: 36249028

The Role of Hepatocyte Nuclear Factor 4α (HNF4α) in tumorigenesis

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Oct 17
PMID 36249028
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte Nuclear Factor 4 Alpha (HNF4α) is a master transcription factor mainly expressed in the liver, kidney, intestine and endocrine pancreas. It regulates multiple target genes involved in embryonic development and metabolism. HNF4α-related diseases include non-alcoholic fatty liver disease (NAFLD), obesity, hypertension, hyperlipidemia, metabolic syndrome and diabetes mellitus. Recently, HNF4α has been emerging as a key player in a variety of cancers. In this review, we summarized the role and mechanism of HNF4α in different types of cancers, especially in liver and colorectal cancer, aiming to provide additional guidance for intervention of these diseases.

Citing Articles

A case of multiple bone metastases during the course of non-invasive bladder and prostate cancer.

Matsubara K, Hayakawa N, Kubota Y, Ohike N, Sunakawa Y, Koike J IJU Case Rep. 2025; 8(2):158-161.

PMID: 40034910 PMC: 11872209. DOI: 10.1002/iju5.12836.


Sex-specific Concordance of Striatal Transcriptional Signatures of Opioid Addiction in Human and Rodent Brains.

Logan R, Shelton M, Horan N, Xue X, Maturin L, Eacret D Res Sq. 2024; .

PMID: 39399686 PMC: 11469374. DOI: 10.21203/rs.3.rs-5006061/v1.


Unveiling the link between arsenic toxicity and diabetes: an in silico exploration into the role of transcription factors.

Fatema K, Haidar Z, Tanim M, Nath S, Sajib A Toxicol Res. 2024; 40(4):653-672.

PMID: 39345741 PMC: 11436564. DOI: 10.1007/s43188-024-00255-y.


Dissecting the -regulatory syntax of transcription initiation with deep learning.

Cochran K, Yin M, Mantripragada A, Schreiber J, Marinov G, Shah S bioRxiv. 2024; .

PMID: 38853896 PMC: 11160661. DOI: 10.1101/2024.05.28.596138.


TSCRE: a comprehensive database for tumor-specific -regulatory elements.

Peng G, Liu B, Zheng M, Zhang L, Li H, Liu M NAR Cancer. 2024; 6(1):zcad063.

PMID: 38213995 PMC: 10782923. DOI: 10.1093/narcan/zcad063.


References
1.
Hu D, Marri S, McKinnon R, Mackenzie P, Meech R . Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma. J Pharmacol Exp Ther. 2018; 368(3):363-381. DOI: 10.1124/jpet.118.255018. View

2.
Lv L, Zhao Y, Wei Q, Zhao Y, Yi Q . Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. Cancer Cell Int. 2020; 20:210. PMC: 7268300. DOI: 10.1186/s12935-020-01298-5. View

3.
Zhou H, Guo L, Yao W, Shi R, Yu G, Xu H . Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency. J Cell Physiol. 2019; 235(3):2113-2128. DOI: 10.1002/jcp.29115. View

4.
Elhodaky M, Hong L, Kadkol S, Diamond A . Selenium-binding protein 1 alters energy metabolism in prostate cancer cells. Prostate. 2020; 80(12):962-976. PMC: 7473137. DOI: 10.1002/pros.24028. View

5.
Ma H, Zhang Q, Yang X, Hu Y, Zhang J, Chen L . HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/-Catenin Pathway. Oxid Med Cell Longev. 2022; 2022:8168988. PMC: 8817108. DOI: 10.1155/2022/8168988. View